Is Lapatinib 250mg Hertab Tablet a cancer treatment?
GlaxoSmithKline developed Lapatinib 250mg Hertab Tablet as an anti-cancer medicine to treat solid tumors including breast and lung cancer. On March 13, 2007, the FDA approved it for use in patients with advanced metastatic breast cancer who were also taking the chemotherapy medication Capecitabine.
What is the best way to consume Lapatinib 250mg Hertab Tablet?
Take this medication by mouth, usually once daily or as advised by your doctor, 1 hour before or after a meal. It is critical that you take this medication only once each day.
What is the purpose of Lapatinib 250mg Hertab Tablet?
Lapatinib is a drug that is used with capecitabine (Xeloda) to treat a specific form of advanced breast cancer in persons who have already received chemotherapy.
In breast cancer, how does Lapatinib 250mg Hertab Tablet?
Tykerb (lapatinib) is a HER2 inhibitor that is used to treat cancer. Tykerb inhibits specific proteins that can induce uncontrolled cell proliferation in HER2-positive breast tumors.
Is lapatinib linked to hair loss?
Oral breast cancer medications such as capecitabine (Xeloda) and lapatinib (Tykerb) can cause hair thinning rather than the severe alopecia that some intravenous chemotherapy treatments can produce.
Is lapatinib associated with diarrhea?
Patients on lapatinib frequently experience diarrhea and dermatologic side effects. Diarrhea can range from mild to severe, depending on the drugs used with lapatinib. Adverse events can lower quality of life, decrease treatment adherence, and lead to therapy cessation.
Can lapatinib make you gain weight?
Shortness of breath or other breathing difficulties, cough, or fever is all signs of lung or breathing disorders. Shortness of breath, significant weight gain, arm or leg edoema Dizziness. Severe diarrhea or diarrhea accompanied by stomach cramps, nausea, vomiting, fever, or fluid loss.
When should you start taking Lenvatinib?
- It’s typically taken once a day, with or without food. Every day, around the same time, take lenvatinib.
Is lapatinib able to pass across the blood-brain barrier?
Because of its small molecular structure, lapatinib can pass the blood-brain barrier. When coupled or alone, lapatinib has been found to inhibit the development of brain metastases in breast cancer patients.